Cyngn Inc. Form 10-Q Summary
Business Context and Reporting Period
Cyngn develops autonomous-driving software and related fleet-management, analytics, and development tools for industrial vehicles. Its Enterprise Autonomy Suite includes DriveMod, Cyngn Insight, and Cyngn Evolve. The company reports one operating segment.
This unaudited report covers the three months ended March 31, 2023, compared with the three months ended March 31, 2022. Cyngn is a non-accelerated filer, smaller reporting company, and emerging growth company.
Key Financial Metrics
| Metric | Q1 2023 | Q1 2022 | Change |
|---|---|---|---|
| Revenue | $872,800 | $0 | New revenue generation |
| Cost of revenue | $616,694 | $0 | New |
| Gross profit | $256,106 | $0 | Gross margin: 29.3% |
| Research and development | $3.03 million | $1.68 million | Up 80% |
| General and administrative | $3.07 million | $2.14 million | Up 45% |
| Loss from operations | $(5.84) million | $(3.82) million | Operating margin: (669.8)% |
| Net loss | $(5.63) million | $(3.82) million | Loss increased 47% |
| Net loss per share | $(0.17) | $(0.14) | Per-share loss increased |
| Net cash used in operating activities | $(5.38) million | $(3.40) million | Cash use increased 58% |
Q1 2023 net loss margin was approximately (644.8)%, calculated from reported revenue and net loss. Revenue was substantially associated with non-recurring engineering contracts; one customer represented 76.8% of revenue.
Balance Sheet, Liquidity, and Capital Structure
- Cash was $8.0 million at March 31, 2023, compared with $10.5 million at December 31, 2022.
- Short-term investments, consisting of U.S. Treasury bills, were $9.0 million, compared with $12.1 million at year-end 2022.
- Total current assets were $18.3 million and total assets were $20.3 million.
- Total liabilities were $913,934, all current. The filing reports no debt balances; operating lease liabilities were $238,600.
- Stockholders’ equity was $19.4 million, down from $24.1 million, primarily reflecting the quarterly net loss.
- Cash and restricted cash declined by $2.6 million during the quarter to $8.0 million.
- Outstanding common shares were 33.7 million at March 31, 2023; 33.8 million were outstanding as of May 11, 2023.
- Potential dilution includes 6.59 million outstanding warrants and 15.52 million outstanding stock options as of March 31, 2023.
Management states that existing cash and short-term investments are sufficient to meet operating and debt-related obligations for at least one year from the report issuance date. However, continued operations depend on increasing revenue, controlling costs, generating positive operating cash flow, and obtaining additional outside financing as needed.
Cash Flow and Investing Activity
- Operating cash use was $5.4 million, driven primarily by the net loss and increased personnel, research and development, and professional-service costs.
- Investing activities provided $2.75 million, reflecting $13.7 million of short-term investment maturities, partially offset by $10.5 million of new investments and approximately $492,000 of property, equipment, and intangible-asset purchases.
- Financing activities provided $6,844 from stock-option exercises.
- The company received approximately $18.1 million of net proceeds from its April 2022 private placement; no comparable financing occurred in Q1 2023.
Material Changes Versus the Prior Comparable Period
- Revenue began in Q1 2023 at $872,800, primarily from non-recurring engineering contracts, versus no revenue in Q1 2022.
- Cost of revenue was $616,694, producing a positive gross profit but insufficient to cover operating expenses.
- Research and development increased by $1.3 million, reflecting higher personnel levels and external contractors.
- General and administrative expense increased by approximately $1.0 million due to personnel costs, stock-based compensation, investor-relations activity, and other public-company expenses.
- Stock-based compensation increased to approximately $925,000 from $520,000.
- Interest income increased to $46,902, and realized gains on short-term investments contributed $169,210 of other income.
- Weighted-average shares increased to 33.7 million from 26.9 million, reflecting prior equity financing and related share issuances.
Guidance, Outlook, Risks, and Unusual Items
- Management expects annual research and development spending in the foreseeable future to equal or exceed 2022 levels.
- Limited paid pilot deployments are expected in 2023, with scaled deployments targeted to begin in 2024.
- The company has not yet generated significant recurring revenue from Enterprise Autonomy Suite subscriptions.
- Revenue remains concentrated and project-based; the company states that substantially all Q1 2023 revenue was associated with non-recurring engineering contracts.
- The company has incurred operating losses since inception and had an accumulated deficit of $141.4 million at March 31, 2023.
- Key disclosed risks include continued funding needs, execution of the commercialization strategy, customer concentration, inflation, rising interest rates, capital-market conditions, supply-chain disruption, geopolitical conflict, cyberattacks, pandemics, and other events beyond the company’s control.
- The Menlo Park office lease expires in August 2023, with approximately $241,000 of remaining payments at March 31, 2023.
- No material pending litigation, material changes to previously disclosed risk factors, or subsequent events requiring recognition or disclosure were reported.
- Management concluded that disclosure controls and procedures were effective as of March 31, 2023, with no material change in internal control over financial reporting during the quarter.
Most Important Facts for Investors to Verify
- Whether Q1 revenue represents repeatable commercial activity or primarily one-time non-recurring engineering work.
- The timing and size of future paid pilots, scaled deployments, and recurring Enterprise Autonomy Suite subscription revenue.
- Cash-burn trends and the expected runway relative to the company’s continuing operating losses and projected research and development spending.
- Potential dilution from 6.59 million warrants, 15.52 million stock options, and other equity awards.
- Customer concentration and the effect of any delayed, terminated, or unprofitable engineering contracts.
- Future financing requirements and the availability and terms of equity or debt financing.
- Whether the reported 29.3% gross margin is sustainable as the business shifts from project work toward product and subscription revenue.